Resmed RMD
NYSE RMD
$231.52 +3.08 (+1.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Resmed (RMD) Income from Non-Controlling Interests (2021)

Resmed's (RMD) quarterly Income from Non-Controlling Interests came in at $48.1 million in Q3 2021, down 9.76% on a QoQ basis from $53.3 million in Q1 2021.

Resmed (RMD) Income from Non-Controlling Interests (2021) Analysis & Trends

Resmed (RMD) has 1 years of Income from Non-Controlling Interests data on file, last reported at $48.1 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 6.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 79.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 48.10 Mn
Mar 31, 2021 53.30 Mn